• EverGen Infrastructure Corp. is a Canadian Renewable Natural Gas (“RNG”) operator creating a world class RNG infrastructure platform
• Renewable natural gas, which is largely obtained as a by-product of decomposing organic waste, has been hailed as a key tool in the global drive towards decarbonization
• EverGen currently operates three organic waste processing and RNG projects in British Columbia, Canada, including Fraser Valley Biogas, Western Canada’s first RNG facility which has been in continuous operation since 2011
• The company anticipates the sector to expand to an annual value of upwards of C$16 billion by 2030

North American Natural Gas prices have risen by over 35% in what may be the most tumultuous start to a year in recent history. Strong demand from across the North American region, coupled with multiple cold fronts, and geo-implications resulting from the Russia-Ukraine war have all come together to drive natural gas prices to some of their highest levels in recent history. Meanwhile, the combination of skyrocketing fossil fuel prices coupled with a global drive to reduce carbon emissions has prioritized the need to seek out alternative energy sources. EverGen Infrastructure (TSX.V: EVGN) (OTCQB: EVGIF), a British Columbia-based RNG developer, owner and operator, has been one of the principal companies involved in the development of Canada’s RNG Infrastructure, a programme seeking to combat climate change and help communities contribute to a sustainable future by acquiring, developing, building, owning and operating a portfolio of renewable natural gas, waste-to-energy and related infrastructure projects. Unlike conventional natural gas, which is obtained through wells and as a by-product of oil drilling, RNG is derived from biogas, which in turn gets captured from decomposing organic waste in landfills, food waste, agricultural waste matter and wastewater from treatment facilities. EverGen, which was founded two years ago by Chase Edgelow, has been designed to simultaneously tackle two of the world’s most pressing environmental issues – decreasing carbon emissions whilst reducing waste. “We need to deal with our waste, as humans,” stated Edgelow in a recent interview. “We need waste infrastructure. But we also want to decrease carbon emissions. So why would we let the energy from that waste infrastructure go straight into the atmosphere and go to waste?” (https://ibn.fm/EFnCx) According to the World Biogas Association, organic waste resulting from food production, farming and landfills is responsible for approximately 25% of methane production, a harmful greenhouse gas. Through its focus on RNG, EverGen Infrastructure harnesses the methane from organic waste to create an environmentally friendly alternative to natural gas, which can subsequently be used to heat homes and even power automobiles. EverGen has already successfully embarked on this goal, through its ownership of Fraser Valley Biogas, Western Canada’s first RNG facility, which has been in continuous operation since 2011. The facility combines anaerobic digesting and biogas upgrading technologies to produce RNG from the manure produced by local dairy farms. The RNG is then contracted to FortisBC, British Columbia’s largest privately-owned utility, which has expressed a desire to source up to 15% of its gas supply from RNG by 2030. With three projects, including Fraser Valley Biogas, currently in its portfolio within the region, EverGen forecasts the sector to balloon to an annual value upwards of C$16billion+ by 2030 (https://ibn.fm/X8j36). Joe Mazza, vice-president of energy supply and resource development for FortisBC, remarked in relation to the company’s drive towards sourcing more of its energy through RNG: “It’s a cost-effective solution for decarbonization.” While RNG is more expensive than traditional natural gas, it comes with the advantage of being a “drop-in fuel,” meaning no costly changes to transmission infrastructure or appliances are required. Cost has historically been an impediment towards widespread RNG adoption; despite its laudable green credentials, a 2019 study prepared for the American Gas Foundation found that the median cost of developing RNG projects was approximately $18 per million BTUs (“MMBTUs”) (https://ibn.fm/YNYd8), a cost which has historically far surpassed that of conventional natural gas. However, and with liquefied natural gas prices hitting a record high of more than $59 per MMBTU in early March 2022 (https://ibn.fm/JhdUY), the idea of an environmentally friendly and renewable alternative to traditional natural gas has rapidly gained attention the world over. While more costly, RNG production generates valuable renewable attributes and a cost effective decarbonization path. As one of the most significant RNG producers in Western Canada, EverGen is well placed to take part in one of the most dramatic shifts within global energy production in recent history. For more information about EverGen Infrastructure Corp. and its projects, please visit www.EverGenInfra.com. NOTE TO INVESTORS: The latest news and updates relating to EVGIF are available in the company’s newsroom at https://ibn.fm/EVGIF

• 37.5 million Americans report some degree of hearing impairment each year, many of which can’t afford the high out-of-pocket costs of prescription hearing aids
• InnerScope offers a comprehensive portfolio of affordable products that do not require a doctor’s prescription
• In recent months, InnerScope has made accretive acquisitions and more than tripled its staff, further cementing its position in the market as Walmart’s biggest provider of hearing aids

There is a case to be made that direct-to-consumer (“DTC”) is the future of hearing aids. Unfortunately, prescription hearing aids are rarely covered by insurance and can cost thousands of dollars. Akin to “cheaters” as a less expensive alternative to prescription reading glasses, personal sound amplification products (“PSAPs”) are available over the counter, but they aren’t as high quality or customizable as prescription hearing aids. Thanks to advancements in technology, companies like InnerScope Hearing Technologies (OTC: INND) are spearheading next-generation products that make hearing aids affordably available without a person having to set foot into a professional’s office. In 2018, the U.S. Food and Drug Administration changed the game with its approval of the Bose Hearing Aid for use in adults 18 years and up with perceived mild to moderate hearing loss. The green light was the first of its type, allowing users to fit, program and control a hearing aid free of assistance from a health care provider. This was music to the ears of some 37.5 million American adults that report hearing issues annually, many of which can’t afford the exorbitant costs of prescription hearing aids. InnerScope offers a full-service platform through its e-commerce site (www.iHearDirect.com) and runs highly targeting marketing of its hearing aids on partners www.FSAstore.com, www.HSAstore.com and www.WellDeservedHealth.com online platforms that cater to consumers enrolled in flexible spending accounts, health saving accounts and employers’ health incentive programs. In recent months, InnerScope has been highly active in the industry, making acquisitions, adding staff, launching new services, and growing revenue as it executes on a scalable and sustainable business model. For example, on the final day of the third quarter, InnerScope completed the acquisition of iHear Medical, a pioneer in DTC hearing solutions with a manufacturing and R&D facility in San Leandro, California, and the owner and developer of the only FDA-cleared in-home hearing test called the iHEARtest, which is sold in CVS pharmacy stores and various online retailers. That was followed less than two months later by the buyout of Virginia Beach, Virginia-headquartered HearingAssist, Walmart’s largest direct-ship and wholesale hearing aid supplier with top-line revenue of more than $72 million since 2018. The impact of these acquisitions will be felt in the upcoming reporting of quarterly performance. The effect could be quite pronounced considering InnerScope this month announced preliminary unaudited revenue results of $633,894 for the quarter ended Dec. 31, 2021. Additionally, early in December, HearingAssist received purchase orders from Walmart for over $277,000 for EZ-Hear Neckband Bluetooth Hearing Amplifiers for an in-store display going into 757 Walmart locations across five U.S. states. Winning consumer loyalty with in-store marketing and services is integral to InnerScope’s growth strategy. In recent months, 14 hearing screening kiosks have been installed at popular retailers such as Hy-Vee, Giant Eagle, Food City, and Hartig Drug stores, with at least 65 more of the 100 under production right now expected to be delivered to retailers by the end of the month. As the company continued to expand, InnerScope recruited and landed Adnan Shennib as CTO and president of International Operations. Shennib brings over 30 years of experience in hearing innovations, having held leading roles with major hearing aid manufacturers, to the company. The addition was part of a surge in job creation that increased the InnerScope team from nine to 30 people. Looking at future product development, InnerScope has filed two new provisional patents and partnered with Atlazo Inc., a leader in intelligent semiconductor solutions for wearable health devices. The partnership will add cutting-edge features to the InnerScope ecosystem, such as voice commands, continuous health monitoring, and seamless connectivity with other smart devices. Feeling the momentum building, Matthew Moore, president and CEO of InnerScope commented, “We have built a team of well-experienced industry leaders in R&D, marketing and distribution, allowing InnerScope to create a proprietary patentable product portfolio and to continue to focus on our execution strategy building a wholesale distribution network of major retailers and pharmacy chains.” For more information on InnerScope Hearing Technologies Inc., visit www.INND.com. NOTE TO INVESTORS: The latest news and updates relating to INND are available in the company’s newsroom at https://ibn.fm/INND

• Following the acquisition of online music distribution company Artist Republik, Friendable has created a 360-degree platform that nurtures independent artists without the constraints of a label
• Fan Pass Live Artist Pro-Services provide artists more options for branding and exposure
• The company has launched merchandise for Spring 2022 for artists and fans, releasing new styles that will be available for a limited time only

Friendable (OTC: FDBL), a mobile technology and marketing company, is pleased to announce that the company’s Fan Pass Live and 360 artist platform has exceeded 111,000 total music artist sign-ups across the platform and corresponding brands. While marking this milestone, XLIVE, a publication that showcases top experts and companies in events and those that develop fan experiences that generate deeper connections and lasting memories, has chosen Friendable for an exclusive article (https://ibn.fm/1l2z1). Robert A. Rositano, Jr., CEO of Friendable, commented on the publication’s interest saying it was a very welcomed opportunity. “Their industry knowledge and understanding of the evolving landscape as it relates to artists, their performances, and how careers are being launched and managed in this new digital age is paramount,” Rositano said. “I’m grateful for the opportunity and believe our current market position as well as the opportunity for our platform and 360 solutions have been framed very nicely in the XLIVE article and look forward to having more artists, fans and the music industry specifically take notice as our business continues to grow on all fronts.” Earlier this year, Friendable completed the acquisition of Artist Republik, an online music distribution company, which has created the current 360-degree artist platform that nurtures independent artists without the constraints of a label. From the moment artists sign up for the Fan Pass Live and Artist Republik platforms, they remain in control of their music but are given the tools necessary to promote and distribute worldwide. Artists can enjoy the Artist Pro Services offering from the Fan Pass Live platform, which helps artists build their brand and attract fans more easily. Pro Services are available in three tiers across three categories – artist/band logo design, merchandise designs and marketing materials, with higher tiers providing more resources for the artist. In fact, during March, artists with the most streams were eligible for prizes ranging from one to three free Pro Service offerings. To stay up to date on all contest offerings, follow Fan Pass Live on Instagram at @fanpasslive. Fan Pass Live has also released its Spring 2022 merchandise line. Each season, the company puts out specialized merchandise for fans and artists alike. The spring collection offers recycled tracksuit pairings, metal water bottles, traditional embroidered t-shirts, hoodies, and crop top varieties. Friendable has big plans for Fan Pass Live and Artist Republik in the future, both of which have demonstrated remarkable growth since the beginning of the year. Plans are already in the works for NFTs and a venture into the Metaverse, which is another effort by Friendable to create more profits for their artists. Currently, artists receive a portion of subscription fees but get 100% of revenue from ticket sales and tips during performances. With roots running deep in the independent music industry – the Rositano brothers have instilled the same passion and dedication into their company. For more information, visit the company’s websites at www.Friendable.com or www.FanPassLive.com. NOTE TO INVESTORS: The latest news and updates relating to FDBL are available in the company’s newsroom at http://ibn.fm/FDBL

• E-commerce and third-party delivery apps will use brick-and-mortar retail locations as fulfillment centers and marketing hubs to boost shopper traffic on the digital platform
• PlantX is positioned to disrupt the global plant-based alternatives market, which is expected to grow to $162 billion over the next years
• Currently offering over 5,000 plant-based products on its platform, PlantX also invests in customer education by providing podcasts, recipes, a dedicated YouTube channel, and blogs for consumers looking to live the plant-based lifestyle

As a key component in diversifying its on-demand delivery solutions, PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF), a one-stop-shop for all things plant-based, recently announced the launch of same-day delivery for its grocery products across Ottawa and Toronto, Ontario. The expansion reflects the PlantX commitment to enhancing its e-commerce capabilities by leveraging PlantX’s retail stores in the Hudson’s Bay in Yorkdale Mall (Toronto) and CF Rideau Centre (Ottawa) (https://ibn.fm/YWirH). “Expanding same-day delivery service to Ontario will help us leverage the combined impact of our e-commerce acumen and our in-store expertise,” PlantX CEO Lorne Rapkin said. “This will ensure that we continue to capitalize on the opportunities offered by the growing retail landscape.” Sean Dollinger, founder of PlantX, added that one of the company’s core goals is to make a plant-based lifestyle accessible to all, which is why it is expanding on its commitment of making plant-based shopping easier for Canadian customers. “By offering consumers trusted same-day delivery options, we build on our legacy of excellent customer service and our goal of becoming the one-stop-shop for everything plant-based in Canada and globally,” Dollinger explained. Third-party delivery apps will facilitate the same-day distribution of plant-based products. In addition to the same-day delivery options, the company plans to enhance the e-commerce impact of its retail stores across Ontario while utilizing its brick-and-mortar retail locations as e-commerce fulfillment centers and marketing hubs to boost shopper traffic on the digital platform. The high demand for alternative, plant-based groceries is expected to create substantial growth in the global plant-based alternatives market, which is anticipated to grow to $162 billion over the next decade from a value of $29.4 billion in 2020 (https://ibn.fm/jdE8S). PlantX is positioned to disrupt the global plant-based alternatives market in physical store locations and online platforms. PlantX is also dedicated to providing customers and visitors to their platform with educational materials, recipes and blog articles. The company offers weekly Vodcasts (“XVodcast”), discussing news and topics important to the plant-based community as well as a wide range of recipes on its website, offering the best plant-based and vegan meal alternatives. The current PlantX offering consists of over 5,000 plant-based products across the platform. Available plant-based products and resources include:

• XGroceries
• XBeverages
• XFitness
• XBeauty
• XRecipes
• XGifts

Additionally, PlantX’s Bloombox club is a service focused on delivering indoor plants to customers. Research and scientific evidence suggest that houseplants reduce stress levels, increase productivity, and boost overall well-being. PlantX is dedicated to the principle that plants and plant-based living are vital to living a healthy life, physically and mentally. For more information, visit the company’s websites at www.PlantX.com, www.PlantX.ca, and https://investor.plantx.com and view PlantX for Plant-Based Investors. NOTE TO INVESTORS: The latest news and updates relating to PLTXF are available in the company’s newsroom at https://ibn.fm/PLTXF

Clearmind Medicine (CSE: CMND) (FSE: CWY0), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics, has announced the fifth webinar in its Psychedelics for Alcoholism series. This segment is titled “Psychedelics for Alcoholism, Q&A with Clearmind Management.” Scheduled for March 30, 2022, this insightful event will feature Clearmind CEO Adi Zuloff-Shani and business development VP Mark Haden. The two experts will discuss the effects of alcohol use disorder (“AUD”) and provide an overview of the company’s proprietary psychoactive molecule, MEAI. In addition, the webinar will include a question-and-answer session, during which key personnel will answer questions related to MEAI and its potential treatment for AUD and binge drinking. MEAI has shown significant promise in its ability to break the addiction cycle. Based on studies and research, MEAI works by potentially innervating neural pathways such as 5-HT1A, which leads to decreased impulsivity and to “sensible behavior.” Because 5-HT1A receptors are associated with controlling craving behavior across the board, MEAI may have a wide range of applications beyond binge drinking. This upcoming event will provide crucial information regarding this novel treatment candidate, the rigorous science behind it, and the potential for the treatment to significantly impact this space. This fifth webinar follows the company’s most recent segment in the series: “Psychedelics for Alcoholism, Investor Deep Dive.” During this webinar, market analyst Marissa Wright provided invaluable insight into the pychedelics market with a focus on psychedelic treatments for alcohol use disorder. After providing a brief explanation of what a sound investment might look like in this market, Wright went on to note key things she looks at when making an investment, such as the valuation spread, exit opportunities and the competitive landscape, including competitive intensity and IP protection. After explaining that she studied 63 different companies in the space and delved into thousands of data sources, Wright had this to say about Clearmind: “In a summary, what does Clearmind look like? Well, they’re hitting a huge social problem, a $249 billion economic impact problem just in the U.S. The market size based on a model I’ve heard is about $4.2 billion revenue potential.” Clearmind has “low competitive intensity—they’ve got a new molecule,” she continued, pointing out that this means broad IP protection. In addition, Wright noted that Clearmind’s potential treatment offers a significant body of anecdotal evidence, indicating efficacy in humans, and is not dependent on expensive behavioral therapies; in addition, based on her research, the company has an 11 to 70 times exit opportunity. “And the alcohol substitute ingredient is a bonus,” Wright concluded. “They’ve got a patent on using MEAI and other psychedelics as a beverage ingredient. What a great way to deliver.” For more information and registration for the next event in the series, please visit https://ibn.fm/7PBlz

• ResearchAndMarkets forecasts a 21.7% CAGR for the global lidar market to reach $3.74 billion by 2026
• Cepton won the largest auto industry lidar contract to date from General Motors, which will use Cepton products in its Ultra Cruise package
• Cepton is well funded after its IPO and is in negotiations with world’s leading auto OEMs, as well as over 120 companies regarding Smart Infrastructure

When carmakers are adding hardware technology to a vehicle even though current software isn’t there yet to maximize the capability, a change is in the works. That’s what is happening with lidar, an acronym for light detection and ranging, that is becoming commonplace in advanced driving assistance systems (“ADAS”) with plans for mass market use one day in autonomous driving. According to Jun Pei, CEO of Cepton (NASDAQ: CPTN), that day is drawing closer, evidenced by widespread adoption by the world’s biggest car brands and Cepton’s support of General Motors’ (NYSE: GM) Ultra Cruise program, that we will see lidar in millions of cars. In its latest industry report, ResearchAndMarkets.com estimated the global lidar market at $1.4 billion in 2021 and experiencing 21.7% compound annual growth, which will result in a $3.74 billion market by 2026. Analysts at the research firm see many market drivers such as vehicles, drones, exploration, smart cities, etc. Lidar uses light pulses to determine the distance objects are away to create a three-dimensional map of the surroundings and evaluate the speed of approaching objects. The technology has been quietly easing its way into the auto space for several years where it is used for things like adaptive cruise control, lane-keep assist, and automatic emergency braking, features collectively known as ADAS. While mostly reserved for higher-end cars, original equipment manufacturers (“OEMs”) are leveraging decreasing costs to make the safety options available in more models while working on next-generation options. Pei saw the future of lidar as integral to autos, setting up a Cepton’s business in Silicon Valley in 2016 with the purpose of developing inexpensive, high performance lidar products that could be mass marketed. And that they did, creating and patenting what it calls MMT(R) lidar solutions. MMT is short for micro-motion technology, a term that encapsulates the benefits of Cepton’s lidar tech over peers insomuch that it doesn’t use mirrors, doesn’t rotate nor have a bunch of moving parts, and consumes very little power, features that caught the attention of Tier 1 auto lighting giant Koito Technologies and General Motors for its Ultra Cruise ADAS option. Koito partnered with Cepton and has made over $50 million in investments in the company in recent years ahead of Cepton coming public in February. Japan-based Koito currently supplies headlight assemblies to GM, which will soon include Cepton sensors used in GM’s vaunted Ultra Cruise feature that will allow cars and trucks to maneuver hands-free around 95% of North America’s roads. Through a combination of lidar, cameras and radars, Ultra Cruise generates an accurate 360-degree, 3D representation of the vehicle’s surroundings, including redundancies in critical areas. Ultra Cruise incorporates lidar behind the windshield, a technology developed exclusively by Cepton. The upstart company says it is engaged with each of the top-10 global automobile OEMs, including advanced engagements with four of those for mass-market vehicle adoption of Cepton lidars. Management guided revenue of approximately $15 million this year (up from $4.5 million in 2021) and cash on hand of more than $100 million at the end of 2022. In line with ResearchAndMarkets.com forecast for integration of lidar into other industries, Cepton trumpets nine production awards and 126 total engagements with Smart Infrastructure customers. Expecting a momentous 2022 for his company as OEMs realize the balance of performance, reliability, and cost of Cepton lidars, Pei recently commented, “We are excited about the long-term opportunity given our competitive advantages and expect to see Cepton lidars in everyday vehicles in the not-too-distant future.” For more information on Cepton Inc., visit www.Cepton.com. NOTE TO INVESTORS: The latest news and updates relating to CPTN are available in the company’s newsroom at https://ibn.fm/CPTN

• LQwD has recently deployed additional routing nodes in Europe, namely in Italy, Sweden, Ireland, England and France
• Since the US-West deployment in November 2021, LQwD has seen 157 nodes interconnected with more than 158 transaction channels over 10 Bitcoin through all channels
• Arcane Research predicts that there will be as many as 700 million Lightning Network users by 2030
• The global cryptocurrency market is expected to reach US$4.94 billion by 2030

LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF), an emerging technology company developing payment infrastructure for the Bitcoin Lightning Network, has announced the deployment of additional European routing nodes. The company’s available European routing nodes include Italy, Sweden, England, Ireland, France, and Germany. Europe contains approximately 43% of all Lightning Network nodes — second to North America. “LQwD’s launch of these additional nodes firmly positions us to increase our overall value on the network,” LQwD CEO Shone Anstey said, commenting on the launch of the new nodes (https://ibn.fm/whNL8). “Being a leading Lightning Network infrastructure and transaction facilitator has a lot of value: First, Lightning Network’s early-movers (like us) are best positioned to strategically expand our position on the network. Second, the more nodes LQwD establishes worldwide, the more transactions can be routed through our node network. And each transaction represents a routing fee.” Since launching the first routing node, US-West, in November 2021, LQwD has seen 157 nodes interconnected with more than 158 transaction channels, routing over 10 Bitcoin through these channels. As of March 16, 2022, the current routing nodes available from LQwD include:

• US-West
  • Capacity: 5.347346880 BTC (US$216,565.78)
  • Channel Count: 94
• Singapore
  • Capacity: 1.774338770 BTC (US$71,860.13)
  • Channel Count: 33
• Germany
  • Capacity: 1.385000160 BTC (US$56,092.05)
  • Channel Count: 24
• Indonesia
  • Capacity: 0.079242420 BTC (US$3,209.29)
  • Channel Count: 2
• France
  • Capacity: 0.062000050 BTC (US$2,510.98)
  • Channel Count: 2
• Ireland
  • Capacity: 0.050000330 BTC (US$2,025.00)
  • Channel Count: 1
• Sweden
  • Capacity: 0.050000440 BTC (US$2,025.00)
  • Channel Count: 1
• Italy
  • Capacity: 0.050000250 BTC (US$2,024.99)
  • Channel Count: 1
• England
  • Capacity: 0.050000150 BTC (US$2,024.99)
  • Channel Count: 1

To follow LQwD’s routing nodes, channels and growth, visit www.1ML.com. The Lightning Network has been expanding significantly over the last 12 months, with Arcane Research predicting that there will be as many as 700 million Network users by 2030. The most recent growth spurt for the network occurred in September 2021, during which El Salvador adopted Bitcoin as legal tender country-wide. It is forecasted that countries where banking access is considered “poor” will be prime candidates for adopting Bitcoin or other cryptocurrencies as legal tender (https://ibn.fm/FOs1V). This increase in demand and popularity are expected to continue driving the global cryptocurrency market’s growth. According to Allied Market Research, the cryptocurrency sector worldwide was valued at US$1.49 billion in 2020. The market is expected to grow at a CAGR of 12.8% during the forecast period, resulting in a value of US$4.94 billion by 2030. Major factors that are anticipated to drive this growth include the need for operational efficiency, transparency in financial payment systems, the rise in demand for remittances in developing countries, an increase in data security, and an improved market cap (https://ibn.fm/Q2IxM). In November 2021, LQwD launched its proprietary platform as a service (“PaaS”) solution for the Lightning Network — lqwd.tech — a global scale Lightning Network infrastructure that allows users to easily deploy, monitor and manage their Lightning Network nodes. The PaaS from LQwD allows individuals to complete transactions with ease without requiring any technical knowledge to do so, and at consistently lower fees. The platform also provides users with API access to the nodes. For more information, visit the company’s website at www.LQwDFinTech.com. NOTE TO INVESTORS: The latest news and updates relating to LQWDF are available in the company’s newsroom at https://ibn.fm/LQWDF

• StraightUp Resources is a mining acquisition and exploration company with flagship properties in Ontario, Canada, and an expanding international footprint
• Following on the acquisition of aerial digital magnetic survey data last year for its flagship properties, the company is preparing a summer work program that will include analysis of its data, identification of key geological targets, and geophysical sampling including a drill program
• The war Russia launched in Ukraine last month has driven some new interest in gold amid concerns about the war’s potential far-reaching impact as well and the immediate impact on Russia’s and the world economy as a result of growing international sanctions
• The Ontario exploration district where StraightUp’s property options are located has historically produced more than 30 million ounces of gold

The gold market has seen recent fluctuations between “war premium” highs over Russia’s assault on Ukraine and the fallout of expected dollar-supporting policies from the U.S. Federal Reserve (https://ibn.fm/cwVbI), although the resultant inflation fear-mongering appears to be easing somewhat (https://ibn.fm/oOsMh). Through it all, gold has maintained its luster for those who regard it as a solution for uncertain times, particularly Russia’s Central Bank, which has been driven to try to strengthen the country’s financial stability in the wake of serious economic sanctions imposed on Russia by numerous countries because of the war (https://ibn.fm/txwEh). Precious metals explorer StraightUp Resources (CSE: ST) (OTCQB: STUPF) is advancing preparations for its summer 2022 work programs in the company’s optioned greenstone belt properties in Ontario, Canada’s Red Lake Mining District — a historically prolific producer of gold (more than 30 million ounces). The work programs will include drilling of the most significant prospects. StraightUp’s flagship properties include the 4,725-hectare (about 11,675 acres) RLX North site and the adjacent 6,275-acre (about 15,505 acres) RLX South site, plus a newly acquired option to purchase the Ranger/Otter mining project adjacent to RLX North that consists of three claims on 1,234 hectares (3,050 acres). The company has two additional projects — Belanger and Ferdinand, at 2,000 hectares (4,942 acres) and 7,143 hectares (17,651 acres), respectively — stretching northeast along the greenstone belt toward the company’s Bear Head gold project (1,944 hectares, or 4,803 acres) in the neighboring Meen-Dempster Greenstone Belt of the Uchi Subprovince. And StraightUp owns the West Cat mine property in southeastern Nevada in the United States, which has reportedly produced some very rich gold ore in a region drawing new excitement for potential prospects. StraightUp is also reviewing the possibility of acquiring the Mallay silver mine and processing plant in the Lima region of Peru, having recently extended a right of exclusivity agreement (“ROE”) for all outstanding shares in Premier Silver Corp., which owns the mine, according to its March 7 statement on the Ranger/Otter option (https://ibn.fm/lnT1Q). StraightUp’s summer exploration programs will include a review and interpretation of historical data on the RLX projects, compiled with new 2021 data to improve the interpretation effort. Following additional examination of the historical drill core, the company will pursue geological mapping and sampling based on the historical data and new soil analysis techniques, as well as geophysical surveys that re-interpret the historical data and the digital magnetic surveys (“MAGs”) conducted from the air last year, according to an investor presentation the company updated this month (https://ibn.fm/IMP72). Exploration of the Belanger Project also planned this summer will largely follow the outline for the RLX properties, with some variation that reflects a different accumulation of historical data on the site. The company is seeking an additional permit for the RLX properties that will allow greater cutting than what was specified in its June 2020 permits, according to the presentation. “We are pleased to further our position in Ontario’s Red Lake Mining District, especially now, given the rapid acceleration of exploration activity and large cap miners interest in the region,” company President and Director Mark Brezer stated in regard to the Ranger/Otter option. Kinross Gold recently acquired Great Bear Resources’ Sobel Project, which is surrounded by the RLX properties, and Kinross is actively pursuing Great Bear Resources’ other prior assets at a total price of about $1.45 billion. For more information, visit StraightUp Resources’ website at www.StraightUpResources.com. NOTE TO INVESTORS: The latest news and updates relating to STUPF are available in the company’s newsroom at https://ibn.fm/STUPF

• Lexaria’s patented DehydraTECH(TM) technology provides faster delivery times, increases bioavailability, increases brain absorption, improves drug potency, reduces administration costs, and masks unwanted flavors
• The epilepsy research will compare the FDA-approved Epidiolex(R) to the company’s proprietary DehydraTECH-CBD formulation
• The global cannabidiol (“CBD”) market had an estimated value of $2.7 billion in 2021 and is expected to reach $111.8 billion by 2030, driven by an increase in demand for CBD use in health and wellness industries

Lexaria Bioscience (NASDAQ: LEXX) (NASDAQ: LEXXW), a global innovator in drug delivery platforms, recently announced that the first phase of its epilepsy research program, EPIL-A21-1, has begun. The research program will assess the seizure-inhibiting activity of cannabidiol (“CBD”) administered via the company’s proprietary DehydraTECH(TM) technology, compared to the only FDA-approved CBD-based seizure medication, Epidiolex(R) (https://ibn.fm/uD9Sa). Epidiolex(R) is the first and only FDA CBD medication for the treatment of seizures associated with two rare forms of pediatric epilepsy — Lennox-Gastaut syndrome and Dravet syndrome. Using DehydraTECH’s advanced drug delivery capabilities, Lexaria hopes to demonstrate superior performance in the research program. The company expects to achieve significant gains in systemic delivery and brain uptake — which have been evidenced and announced from other studies comparing the DehydraTECH 2.0 CBD formulations with concentration-matched controls. Lexaria believes this could improve therapeutic efficacy for multiple conditions of the nervous system, including but not limited to epilepsy. The EPIL-A21-1 research program contains two main studies to be performed in rodents following the first phase — a pilot animal model that has already begun. The main studies are slated to commence in May/June and involve an acute seizure model induced by electrical stimulation and chemically induced seizure models. Lexaria has chosen these models because they were previously selected by other researchers studying the antiepileptic effects of CBD during the Epidiolex formulation. The DehydraTECH-CBD test articles needed to commence dosing have already been manufactured and delivered to the third-party laboratory tasked with completing the research program. Lexaria will release updates on the studies occasionally beginning in Q3, 2022. Lexaria’s DehydraTECH technology is designed for formulating and delivering lipophilic (fat-soluble) drugs and active ingredients. DehydraTECH increases effectiveness and improves the way active pharmaceutical ingredients enter the bloodstream. Benefits of the DehydraTECH technology include:

• Faster delivery times — subjects begin to feel the effects of the product in minutes
• Increase in bioavailability — the technology is more efficient at delivering products into the bloodstream
• Increased brain absorption — testing suggests that DehydraTECH significantly improves the amount of drug delivered across the blood-brain barrier
• Improved drug potency — more ingested product is made available to the body, requiring lower dosages to achieve the same desired effect
• Reduction in drug administration costs — lower doses translate to lower administration costs
• Masks unwanted taste — the technology eliminates or reduces the need for sweeteners

By leveraging its technology, Lexaria Bioscience can successfully tap into the ever-growing CBD market. The global CBD sector had an estimated value of $2.7 billion for 2021 and is expected to grow at a CAGR of 51% by 2030, reaching a value of $111.8 billion (https://ibn.fm/6sjWu and https://ibn.fm/4LKbw). The increase in demand for CBD use in the health and wellness market is the primary driver of growth. As CBD becomes legal in more regions, it is attracting the attention of e-commerce platforms — with North America dominating the market. The growth can also be attributed to the increased adoption of technology and overall greater investments in research and development opportunities. For more information, visit the company’s website at www.LexariaBioscience.com. NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX

• Lexaria has received a new patent entitled “Compositions Infused with Nicotine Compounds and Methods of Use Thereof”
• The new patent, granted in Australia, is the first awarded from Lexaria’s 8th patent family and offers IP protection across a total of 9 claims
• Lexaria believes the patent could be meaningful as it seeks to build value
• With the new patent, Lexaria’s IP portfolio has now grown to 24 granted patents worldwide

In his letter to shareholders dated January 27, 2022, Lexaria Bioscience (NASDAQ: LEXX) CEO Chris Bunka documented the company’s expectation that it would receive additional patents in 2022. The expected patents would build on the company’s already solid intellectual property (“IP”) portfolio that expanded severalfold last year when Lexaria was awarded five new patents. The then newly granted patents brought the company’s total to 23 granted patents worldwide as of December 2021 (https://ibn.fm/xSXj1). And in an announcement that fulfills part of the company’s expectations for 2022 as well as expands its impressive IP portfolio even further, Lexaria recently reported it had been awarded a new patent entitled “Compositions Infused with Nicotine Compounds and Methods of Use Thereof” (https://ibn.fm/rlxbH). Granted in Australia, the new patent expands on the company’s international IP rights to apply DehydraTECH(TM) technology to most forms of nicotine, namely sprays, gums, lozenges, pouches, capsules, tablets, and pills. It also covers multiple disparate forms of nicotine, including polymer resins of nicotine, freebase nicotine, and other nicotine complexes. Following the receipt of this most recent patent, which is the first patent awarded from its 8th patent family, Lexaria’s IP portfolio has grown to 24 granted patents; the Australian patent offers IP protection across a total of 9 claims and is set to expire in April 2039. Moreover, according to the company, corresponding patent applications within this patent family are currently pending in other jurisdictions, including the U.S. Lexaria is a global innovator in drug delivery platforms. Its flagship drug delivery technology, DehydraTECH, has been proven, through animal and human studies, to increase bioavailability, brain absorption, and the speed of onset of active pharmaceutical ingredients, as well as mask their unwanted tastes. In one such animal study — the oral nicotine absorption study NIC-A21-1 — whose results were announced in October last year, Lexaria established that DehydraTECH-processed nicotine delivered through the oral pouch product format “required only 2 to 4 minutes to deliver nicotine levels in blood plasma comparable to levels achieved at 45 minutes with concentration-matched controls” (https://ibn.fm/GvCD1). In earlier studies conducted in 2018, the company also revealed that DehydraTECH improved the peak nicotine delivery as well as the speed at which nicotine was delivered to the bloodstream. Moreover, Lexaria established that DehydraTECH for oral nicotine resulted in higher brain levels of nicotine compared to controls (https://ibn.fm/OBHO8). The studies and their groundbreaking results demonstrate the company’s progress toward improving oral nicotine products. In this regard, the protection offered by the granted patent, Lexaria believes, could contribute substantially toward the company’s ability to build value. Speaking during the Benzinga Global Small-Cap Conference held late last year, George Jurcic, Lexaria’s Head of Investor Relations (“IR”), noted that the company already has a patent granted in Australia to use DehydraTECH-processed cannabidiol (“CBD”) to potentially treat heart disease. “We have a disruptive drug technology with multiple opportunities for success in cannabinoids, nicotine, antivirals, and other active pharmaceutical ingredients,” said Jurcic (https://ibn.fm/ofDsw). Thus, the new Australian patent covering the use of DehydraTECH-nicotine builds on the existing IP protection there and sets the stage for the company to exploit nicotine- and CBD-oriented opportunities within this market. For more information, visit the company’s website at www.LexariaBioscience.com. NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX